Plasma levels of carbamazepine and carbamazepine-10,11-epoxide during treatment of epilepsy
- 1 January 1976
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Pharmacology
- Vol. 9 (5-6), 417-421
- https://doi.org/10.1007/bf00606558
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Determination of carbamazepine and its epoxide metabolite in plasma by high-speed liquid chromatographyJournal of Chromatography A, 1975
- Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple dosesEuropean Journal of Clinical Pharmacology, 1975
- Carbamazepine for epilepsyNeurology, 1974
- Concentration of Carbamazepine (Tegretol®) in Serum and in Cerebrospinal Fluid in Patients with EpilepsyEpilepsia, 1973
- Preliminary observations of serum carbamazepine concentration in epileptic patientsNeurology, 1973
- Mass Spectrometric Characterization of Carbamazepine-10,11-epoxide,a Carbamazepine Metabolite Isolated from Human UrineJournal of Pharmaceutical Sciences, 1972
- Tegretol (Carbamazepine): A Controlled Trial of a New Anti-ConvulsantThe British Journal of Psychiatry, 1966
- Some Causes of Ineffectiveness of DiphenylhydantoinArchives of Neurology, 1966
- Tic Douloureux Treated With New AnticonvulsantArchives of Neurology, 1963
- Clinical and Electroencephalographic Correlations with Serum Levels of DiphenylhydantoinArchives of Neurology, 1960